The Vioxx scandal means trouble for pharmaceutical and biotech companies' 2005 marketing and sales, Florida-based Strategic Research Institute said Friday. Other factors negatively affecting the industry is a lack of new blockbuster drugs, market fragmentation and pricing/re-importation pressures, the institute said. All have converged to create a business climate "dramatically different from that of the 1990s when double-digit earnings and flood of new drugs were common." The Strategic Research Institute creates, produces and manages conferences covering industry specific business-to-business topics. © Copyright 2005 by United Press International

---

Copyright ©2025— Trib Total Media, LLC (TribLIVE.com)

---